VIP (Vasoactive Intestinal Peptide)

VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide studied in controlled laboratory settings for its interaction with VPAC1 and VPAC2 receptor pathways. As a member of the secretin/glucagon peptide family, VIP has been investigated for its role in smooth muscle signaling research, neuroimmune communication pathways, and intracellular cyclic AMP (cAMP) modulation mechanisms. Due to its broad receptor distribution, it remains a compound of interest in gastrointestinal, pulmonary, and neuroendocrine research frameworks. Preclinical investigations have examined VIP for its influence on vasodilatory signaling models, inflammatory mediator pathway research, and peptide-receptor binding dynamics. Ongoing scientific studies continue to evaluate its molecular behavior in endocrine signaling systems, immune-modulatory research environments, and cellular communication networks under controlled laboratory conditions. This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. VIP (Vasoactive Intestinal Peptide) is intended strictly for laboratory research and analytical purposes only and is not for human consumption.